LGALS3 Recombinant Protein
Source : Escherichia Coli. LGALS3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 249 amino acids and having a molecular mass of 26kDa.The LGALS3 is purified by proprietary chromatographic techniques. Galectin-3 mediates with the alpha-3, beta-1 integrin the stimulation by cspg4 of endothelial cells migration. Galectin-3 plays an necessary part during the acquisition of vasculogenic mimicry and angiogenic properties associated with melanoma progression. LGALS3 overexpression is highly expressed in early stages of papillary carcinoma, and its expression intensity declines during tumor progression. Serum levels of LGALS3 are high in patients with thyroid malignancy but there is considerable overlap in serum LGALS3 concentrations between those with benign and malignant nodular thyroid disease. LGLAS3 takes part as an immune regulator to inhibit T-cell immune responses and promote tumor growth, as a result providing a new mechanism for tumor immune tolerance.
Product Specifications
Product Name Alternative
Purification
Greater than 97.0% as determined by analysis by SDS-PAGE and HPLC.
Components
The Galectin-3 protein was lyophilized from a 0.2μm filtered concentrated solution in PBS, pH 7.4 and 3mM DTT.
Storage Conditions
Applications Notes
Amino Acids
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items